Assessing the Use of Nicotine Gum to Decrease Betel Nut Chewing in Saipan
Status:
Not yet recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
The study will include a prospective, randomized, double-blinded trial, with a total of 45
subjects enrolled. Research subjects will be recruited from a population of adult patients
(current patients at Commonwealth Healthcare Corporation) 18 years or older who are daily
betel nut chewers who add tobacco to their chew. One of the study team members will be
traveling to Commonwealth of Northern Mariana Islands and a letter of support has been
obtained in order to conduct the study.
Eligible patients must be non-tobacco smokers, be actively interested in betel nut reduction
or cessation, and chew at least four times a day on average. Subjects will be randomized
equally into three distinct groups for the purpose of this study:
- non-medicated regular chewing gum
- nicotine 2 mg gum
- nicotine 4 mg gum